Astellas is dedicated to contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. Our VISION is on the forefront of healthcare change to turn innovative science into value for patients.
Since its establishment in 2013, Astellas Innovation Management (AIM) has been playing an essential role in promoting intake early-stage innovation into Astellas through collaboration with external partners.
Located both in Cambridge, Massachusetts and Menlo Park, California, in where innovative science is actively arising, AIM has robust and wide spread networks in healthcare industry, and flexible partnering structures.
We are determined to turn innovative science into value for patients with our collaboration partners.